How much information in patents is available elsewhere?
In THE DISCLOSURE FUNCTION OF THE PATENT SYSTEM (OR
LACK THEREOF), 118 Harv. L. Rev. 2007 (2005), it is argued that the patent system fails in its disclosure function and that most information in patents is (freely) available elsewhere. In a recent release by Research and Market [below], it is stated that 75% of the information in patent documents is not available elsewhere. Which is the correct picture?
Of another point in the Harvard Law Review, the idea that commercialization of valuable inventions is probably the most important rationale of the patent system is simply wrong. We do not want the government intervening in a free market economy by issuing patents only on what government officials think likely to be commercialized. The present system grants limited time rights to exclude in return for disclosure. The public gets the disclosure and business people figure out what to commercialize.
**
Research and Markets (www.researchandmarkets.com) has announced the addition of Patent Analysis of Adenosine A2A Receptor Agonists to their offering.
This is a competitive intelligence report of Adenosine A2A Agonists utilizing patent analysis. Extensive patent mining techniques were utilized to produce a base patent set of 202. This base set was then organized and analyzed for competitive intelligence. It has been reported that 75% of the information in patent documents is not available elsewhere. Therefore, this report provides valuable non-scientific literature data organized for actionable intelligence.
The data from this report was collected through October 2004. The patent databases utilized were the USPTO (United States Patent and Trademark Office), EPO (European Patent Office), WIPO (World Intellectual Property Organization), DPMA (German Patent and Trade Mark Office) and the JPO (Japan Patent Office).
Research and markets claims to give information on:
Highlights:
-- Comprehensive patent overview of Adenosine A2A receptor agonists
-- Backward and Forward Citation Maps [Oh no, patent citation...]
-- Innovation Speed and Patent Strength Indicators
-- Patent Distribution Charts of each company
This report will give you an overview of major and minor players in the field. It enables you to assess your position in this area of research and discover potential acquisition targets. From reading this report you will learn the "Patent Strengths" of key patents.
LACK THEREOF), 118 Harv. L. Rev. 2007 (2005), it is argued that the patent system fails in its disclosure function and that most information in patents is (freely) available elsewhere. In a recent release by Research and Market [below], it is stated that 75% of the information in patent documents is not available elsewhere. Which is the correct picture?
Of another point in the Harvard Law Review, the idea that commercialization of valuable inventions is probably the most important rationale of the patent system is simply wrong. We do not want the government intervening in a free market economy by issuing patents only on what government officials think likely to be commercialized. The present system grants limited time rights to exclude in return for disclosure. The public gets the disclosure and business people figure out what to commercialize.
**
Research and Markets (www.researchandmarkets.com) has announced the addition of Patent Analysis of Adenosine A2A Receptor Agonists to their offering.
This is a competitive intelligence report of Adenosine A2A Agonists utilizing patent analysis. Extensive patent mining techniques were utilized to produce a base patent set of 202. This base set was then organized and analyzed for competitive intelligence. It has been reported that 75% of the information in patent documents is not available elsewhere. Therefore, this report provides valuable non-scientific literature data organized for actionable intelligence.
The data from this report was collected through October 2004. The patent databases utilized were the USPTO (United States Patent and Trademark Office), EPO (European Patent Office), WIPO (World Intellectual Property Organization), DPMA (German Patent and Trade Mark Office) and the JPO (Japan Patent Office).
Research and markets claims to give information on:
Highlights:
-- Comprehensive patent overview of Adenosine A2A receptor agonists
-- Backward and Forward Citation Maps [Oh no, patent citation...]
-- Innovation Speed and Patent Strength Indicators
-- Patent Distribution Charts of each company
This report will give you an overview of major and minor players in the field. It enables you to assess your position in this area of research and discover potential acquisition targets. From reading this report you will learn the "Patent Strengths" of key patents.
posted by Lawrence B. Ebert at 4:54 AM
0 Comments:
Post a Comment
<< Home